Tumgik
#Cowishield
harpianews · 3 years
Text
60 lakh for Covishield, 15 lakh for Covaxin: Health officials urge Maharashtra residents to take second dose
60 lakh for Covishield, 15 lakh for Covaxin: Health officials urge Maharashtra residents to take second dose
State health officials have urged citizens to take a second dose of the Covid-19 vaccine within the stipulated period. Dr Pradeep Vyas, Additional Chief Secretary (Health), Maharashtra said Indian Express That at least 60 lakh beneficiaries are due for the second dose of Covashield while 15 lakh are due for the second dose of Covaxin. He said that Maharashtra has more than 3 crore fully…
View On WordPress
1 note · View note
nipafitnessworld · 3 years
Photo
Tumblr media
💁Finally I Completed Second Jab of VaccInation.... 💁 But still Mask 😷 and Social distancing is Compulsory....💁 Stay home | Stay Safe | Stay Healthy | #cowishield #vaccination #secondshot #stayhealthyandfit #maskon #careforyou #careforall https://www.instagram.com/p/COmqps-HNTu/?igshid=95dsc0bwltil
0 notes
harpianews · 2 years
Text
No mixing, only one jab of precautionary dose of Covid, says government
No mixing, only one jab of precautionary dose of Covid, says government
The government clarified on Wednesday that the “precautionary” vaccine dose to be given to healthcare and frontline workers and persons aged 60 years and above would be the same as the first two doses. Addressing the media, NITI Aayog member Dr Vinod K Paul said, “Those who have got Covaxin will get Covaxin. Those who have received the primary two doses of Covishield will receive Covishield.…
View On WordPress
0 notes
harpianews · 2 years
Text
COVID: Registration for kids 15-18 will start from tomorrow for their first shot; 10 crore target population
COVID: Registration for kids 15-18 will start from tomorrow for their first shot; 10 crore target population
Active Kovid case load across the country crossed 1 lakh on Saturday, register for this Vaccination of children 15 to 18 years, an important milestone in expanding immunity beyond adults, which is in progress. Data from the Coin Dashboard showed 3,15,416 registrations for this age group as of 11.30 pm on Saturday. Union Health Minister Mansukh Mandaviya appealed Parents register your eligible…
View On WordPress
0 notes
harpianews · 2 years
Text
Booster boosts antibodies, improves protection against omicrons: Scientist
Booster boosts antibodies, improves protection against omicrons: Scientist
A booster dose against COVID-19 increases the amount of circulating antibodies and has been shown to increase protection against symptomatic infection with Omicron, scientists say, adding that a booster may be the simplest step, specifically For immunosuppressed. Responding to the UK Health Security Agency’s (UKHSA) statement that a booster dose of the effective COVID-19 vaccine against Omicron…
View On WordPress
0 notes
harpianews · 2 years
Text
SII may cut monthly production of Covishield by half amid fall in demand
SII may cut monthly production of Covishield by half amid fall in demand
With the central government not having enough orders for Covidshield, Serum Institute of India (SII) CEO Adar Poonawalla on Tuesday said the company is reducing the monthly production of vaccines by at least 50 per cent. SII has written to the government seeking clarity on its requirement, if any, on the usual two doses and booster doses for eligible people in the country. “I am really in a…
View On WordPress
0 notes
harpianews · 2 years
Text
Government approves commercial export of Covishield, Covaxin in view of sufficient stock
Government approves commercial export of Covishield, Covaxin in view of sufficient stock
Official sources said on Thursday that the central government has allowed commercial export of Covishield and Covaxin in view of the adequate stock of COVID-19 vaccines available with the states and union territories as well as manufacturers. However, the quantity of COVID vaccines to be exported will be decided by the government every month to ensure that there is no shortfall in domestic…
View On WordPress
0 notes
harpianews · 2 years
Text
First real-world study: Covaxin effectiveness 50%
First real-world study: Covaxin effectiveness 50%
Two doses of Covaxin have 50 percent effectiveness against symptomatic COVID-19, suggests the first real-world evaluation of the effectiveness of a vaccine developed in India. The study, published in the journal The Lancet Infectious Diseases, assessed 2,714 hospital workers at AIIMS, New Delhi who were symptomatic and underwent RT-PCR test for coronavirus between April 15 and May 15 this year.…
View On WordPress
0 notes
harpianews · 2 years
Text
India-made Covaxin now on UK approved travel list
India-made Covaxin now on UK approved travel list
Bharat Biotech-manufactured Covaxin, one of the vaccines being offered to protect against Covid-19 in India, is on the UK’s list of approved COVID-19 vaccines for international travelers from Monday. It will further benefit fully vaccinated Indians planning to travel to the UK without the need for pre-departure PCR testing or self-isolation at the address declared on their mandatory passenger…
View On WordPress
0 notes